Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Authorship and citation trends in dementia research: A path to equitable career development for scientists.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning.

medRxiv : the preprint server for health sciences·2026
Same author

Intraindividual cognitive variability predicts amyloid beta, tau PET, and dementia conversion in Down syndrome: a potential marker of cognitive resilience.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society.

Neuromolecular medicine·2026
Same author

CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progression.

medRxiv : the preprint server for health sciences·2026
Same author

Complex interplay of astrogliosis and pathology in preclinical Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

生物标志物 生物标志物

Laura Alejandra Ramirez Tirado1, Ann D Cohen1,2,3, C Elizabeth Shaaban1,2

  • 1University of Pittsburgh, Pittsburgh, PA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 13, 2026
PubMed
概括
此摘要是机器生成的。

周围炎症标志物 (TNFR1,TNFR2) 与星病 (GFAP) 结合,显著增加粉素β阳性个体中阿尔茨海默病痴呆风险和死亡率.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

744

相关实验视频

Last Updated: Jan 14, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

744

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 老年学是一门学科.

背景情况:

  • 以前的研究表明,瘤坏死因子受体1 (TNFR1) 和TNFR2与星结合有协同作用,导致血管负担增加和神经退行,特别是在粉样蛋白β阳性 (Aβ+) 个体中.
  • 这项研究调查了外周炎症和星病对阿尔茨海默病 (AD) 痴呆和死亡率的综合影响.

研究的目的:

  • 评估外周炎症标志物 (TNFR1,TNFR2) 和星病 (GFAP) 之间的相互作用,以预测AD痴呆的发病率和死亡率.
  • 测试这一假设,即星病和外周炎症之间的协同效应加速痴呆症的进展,增加死亡率,特别是在Aβ+参与者中.

主要方法:

  • 利用了Gingko评估记忆 (GEM) 研究的数据,包括PiB-PET扫描,GFAP和通过免疫检测测测量的外周炎症标志物 (TNFR1,TNFR2).
  • 采用考克斯的比例危险模型来评估炎症,星病和结果之间的关系,并根据关键共变量进行调整,包括年龄,性别,教育,APOEε4,囊素C和基线Aβ状态.

主要成果:

  • 在Aβ+参与者中,高水平的GFAP与TNFR1或TNFR2结合显示出显著的加法和乘法相互作用,增加痴呆风险 (TNFR1:HR 4.55,p=.032;TNFR2:HR 4.07,p=.012).
  • 高TNFR1水平与死亡风险增加有关 (HR1.50,p=.046),在Aβ+个体中观察到GFAP和TNFR2之间对死亡率产生协同效应 (p=0.036).
  • 虽然Aβ+状态独立增加了痴呆风险 (HR 1.73,p=.016),但单独的TNFR1和TNFR2在完全调整后并不能显著预测痴呆发病率.

结论:

  • 星病 (GFAP) 和外周炎症 (TNFR1,TNFR2) 之间的相互作用对于预测Aβ+个体的AD痴呆症进展和死亡率具有临床意义.
  • 这些发现强调了联合炎症和质激活途径在驱动AD病变和结果中的关键作用.